Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eran E Bram

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
ACS Synthetic Biology|June 15, 2013
Genetically programmable pathogen sense and destroySaurabh Gupta, Eran E Bram, Ron Weiss
Biochemical and Biophysical Research Communications|September 27, 2008
PCFT/SLC46A1 promoter methylation and restoration of gene expression in human leukemia cellsNitzan Gonen, Eran E Bram, Yehuda G Assaraf
Neoplasia (New York, N.Y.)|December 19, 2009
Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistanceEran E Bram, Michal Stark, Shachar Raz, et al.
The Journal of Biological Chemistry|November 12, 2010
Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistanceMichal Stark, Eran E Bram, Martin Akerman, et al.
Molecular Pharmacology|March 3, 2009
Structural determinants of imidazoacridinones facilitating antitumor activity are crucial for substrate recognition by ABCG2Eran E Bram, Yamit Adar, Nufar Mesika, et al.
Biochemical Pharmacology|May 8, 2007
C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cellsEran E Bram, Ilan Ifergan, Michal Grimberg, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
ACS Synthetic Biology|June 15, 2013
Genetically programmable pathogen sense and destroySaurabh Gupta, Eran E Bram, Ron Weiss
Biochemical and Biophysical Research Communications|September 27, 2008
PCFT/SLC46A1 promoter methylation and restoration of gene expression in human leukemia cellsNitzan Gonen, Eran E Bram, Yehuda G Assaraf
Neoplasia (New York, N.Y.)|December 19, 2009
Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistanceEran E Bram, Michal Stark, Shachar Raz, et al.
The Journal of Biological Chemistry|November 12, 2010
Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistanceMichal Stark, Eran E Bram, Martin Akerman, et al.
Molecular Pharmacology|March 3, 2009
Structural determinants of imidazoacridinones facilitating antitumor activity are crucial for substrate recognition by ABCG2Eran E Bram, Yamit Adar, Nufar Mesika, et al.
Biochemical Pharmacology|May 8, 2007
C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cellsEran E Bram, Ilan Ifergan, Michal Grimberg, et al.
Pageof 1